Solid phase antibody screening in the presence of anti-CD38 monoclonal antibodies: a potential alternative to avoid
J Perram1, B Blayney2, L Ackerman2
1Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Blood Bank NSW Health Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Pathology
|May 2, 2020
Abstract
No abstract available in PubMed .
More Related Videos
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
9.2K
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
966
